Mr. Abel brings over 25 years of medical device and specialty pharma experience to AAT, including senior roles at Allergan and Biogen, as well as CEO and Chief Business Officer roles at several start-ups. He was a member of the BOTOX® leadership and launch team that built and executed Allergan's re-entry into dermatology and was the global lead for BOTOX® aesthetic and hyperhidrosis development and commercial launch efforts. As VP of Dermatology at Biogen, he built and led the team that launched the first Biologic approved for psoriasis. Also, while General Manager of Onset Dermatologics, he led the development of multiple products and grew revenue by more than 6-fold. He holds a BA in Chemistry from Lafayette College and an MBA from Temple University.

Mr. Burtt brings over 35 years of senior management experience to Advanced Aesthetic Technologies, Inc., including previous positions at Medtronic and IBM. He has raised over $50 million in angel and venture capital in his management capacity and co-founded or led five companies to acquisitions. Mr. Burtt holds an MS in Chemical Engineering from the University of Massachusetts and the Professional Director Certification for Public Companies from the American College of Corporate Directors.

A board-certified plastic surgeon, Dr. Miller has more than 25 years of experience in cosmetic plastic surgery and facial rejuvenation procedures. He helped found PureTech Ventures, a biomedical seed fund, and Environ USA, a cosmeceutical company. As the Clinical Founder of ThermiAesthetics, Inc., he helped develop a therma-controlled radiofrequency technology for skin tightening and nerve ablation. He is currently the CEO of Medical Aesthetic Technology Corporation (MATC), which develops nanotechnology for cosmetic delivery systems. Dr. Miller attended medical school at the University of Cape Town and was further trained at Groote Schuur Hospital, Peter Bent Brigham Hospital, Harvard Surgical Services, and Emory University Affiliated Hospitals. In addition to running a leading private plastic surgery practice in Boston, Dr. Miller serves as a Clinical Instructor in Surgery at Harvard Medical School and as a staff surgeon at Beth Israel Deaconess Hospital.

John Preston is the former Director of Technology Development (and Licensing) at MIT where he was responsible for the commercialization of MIT-developed technologies. Of the companies started during his tenure, those that went public have a cumulative market capitalization estimated to be above $100 billion. Mr. Preston was awarded the rank of “Knight of the Order of National Merit of France” by French President Mitterrand and the “Hammer Award for Reinventing Government” by Vice President Gore. He chaired President George H. W. Bush’s conference announcing the President’s technology initiative and has previously served as a Board Advisor to Mars Incorporated.

A board-certified plastic surgeon, Dr. Kinney is Deputy Secretary General of the International Confederation of Plastic, Reconstructive and Aesthetic Plastic Surgeons (IPRAS), former member of the Board of Directors of the American Society of Plastic Surgeons, past President of the Plastic Surgery Educational Foundation and past Chairman of the Board of Trustees of the American Society of Plastic Surgeons. A staff member of St. John’s Hospital and Health Center and Cedars-Sinai Medical Center, Dr. Kinney is also a Clinical Associate Professor of Plastic Surgery at USC School of Medicine. He serves as a consultant to biotech and engineering companies and has authored numerous journal and magazine articles and co-edited a standard textbook of Plastic Surgery, Plastic Surgery: Indications and Practice. Dr. Kinney earned his bachelor’s and master’s degree in the Harvard/MIT Health Sciences and Technology program. He received his Medical degree at Tulane University Medical School and trained in general surgery and plastic surgery at UCLA Medical Center. As a team leader in new technologies, Dr. Kinney has participated in three US FDA clearances and in numerous FDA clinical trials.

Mr. Sayare spent over 25 years as CEO and Founder of ImmunoGen, Inc. During his tenure, he led the Company through four private rounds of venture financing and to an IPO in 1989, totaling over $500 million in capital formation. Dr. Sayare also serves as Chairman of the Board of PharmaAthene, Inc., is a Director of Boston IVF, Isabella Products, and Cymogen DX. He is a member of the scientific advisory board of LA BioMed and the Harbor-UCLA Medical Center, where he also serves as a member of the board executive committee. Dr. Sayare holds a PhD in biochemistry from Temple University Medical School and was a former assistant professor of biochemistry at the University of Connecticut.

Mr. Rogal’s career spans over 30 years in the high tech electronics industry. He is currently Chairman and CEO of Gold Circuit Electronics, a leading manufacturer of high technology printed circuit boards. Prior to Gold Circuit, Peter founded Comtel Electronics and Comtel Security Systems, which were acquired by Palomar Corporation in 1998. He was also Chairman and CEO of Beacon Endoscopic, Inc., which was recently acquired by Covidien, and was founder of Brooktrout Ventures, an investment and marketing firm. Mr. Rogal is a graduate of Ithaca College.

For the last 9 years, Paul has been the owner and managing director of Elzer Services LTD, which provides accounting and financial assistance to hedge funds, insurance companies, and other clients. He also serves as a director, and managing director of Algeness - Europe, AAT’s European subsidiary. Mr. Sinnott has served as an independent non-executive director, Finance Director and Chairman on a number of various Boards. He has worked for over thirty five years in a number of financial roles across a wide variety of industry sectors ranging from financial services to software development to the leisure industry. Paul has a hands on, common sense, can do approach with an open collaborative style. He is results orientated with a proven track record of developing businesses to their true potential. He is an experienced private investor and has been a member of the Institute of Chartered Accountants in Ireland since 1981. He has served as a director of AAT since 1/09/2018.

John Cammett is Co‐Founder of Realterm Global, a vertically integrated industrial real estate development and investment management company, with a primary focus on transportation facilities serving the global supply chain. Realterm owns and manages over 300 facilities totaling $4.5 billion in investment. John led the company from its initial air cargo development in Montreal, Quebec in 1991 to its current airport industrial real estate portfolio of 35 airports. He is a graduate of Harvard College, with a bachelor’s degree in engineering and applied sciences.

Mr. Gitto has spent 20 years as an Executive Director in the medical and beauty industries. Prior to his position as AAT’s COO, he was COO for LPG Systems, world leader in the production of medical devices for cellulite treatment, body contouring, and physiotherapy indications. He was also Vice President of Siyanli Co. Ltd, one of the largest high end spa and medical-spa and aesthetic clinics in China. He was also a board member of the Sophia Biotech association in France. He is fluent in 5 languages, is graduated in economics and management and has an advanced degree in marketing from the Universite Nice Sophia Antipolis, in France.

Mr Tinkham has had a successful career in both early stage and large cap healthcare companies, both operationally as well as M&A experiences. He is currently President & CEO of GI Windows a company in which he was an original founder. He is recognized as a leader in innovation and entrepreneurship as an invited speaker and faculty for multiple Gastroenterology & Hepatology societies both US and International. His past experiences include, Vice President of Sales and Vice President of New Technologies for Medtronic. Prior to Medtronic, Mr Tinkham was the Co-Founder of Beacon Endoscopic (acquired by Covidien 2014) and held global marketing & sales leadership positions at Boston Scientific.